PRDX6 and hepatocellular carcinoma: Specifically, the expression of PRDX6 is documented to elevate in the sera of patients with lung squamous cell carcinoma [147] or hepatocellular carcinoma [160], but decrease in both the sera of patients with esophageal or colon carcinoma [147] and the interstitial fluid of patients with breast cancer [158].